II

Intellia Therapeutics, Inc.

Request removal

Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system. The promise of the CRISPR/Cas9 system is the driving force behind the creation of Intellia. Our founders have a shared belief that the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. This technology offers the potential for us to develop curative therapeutic options for patients with chronic diseases by addressing the underlying cause of the disease. It can bring new hope and cures to people who now have nowhere to turn for help. Our combination of deep scientific expertise and clinical development experience, along with our leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. Intellia has the right people, assets and ambitious vision needed to take full advantage of the CRISPR/Cas9 technology's attributes – high potency, specificity, simplicity of use, broad applicability, and multifunctional programmability – and accelerate the advancement of curative products into the clinic. View our social media community guidelines at https://www.intelliatx.com/terms-and-conditions/ .

Get valid emails for people working at Intellia Therapeutics, Inc. and 200M other companies
20 free emails each month. No credit card required.
500M
Business Profiles
20M
Company Profiles
200M
Email addresses
98%+
Email Delivery
Intellia Therapeutics, Inc.'s headquarter address
Line 1: 40 Erie Street, Cambridge, Massachusetts 02139, US
Line 2: 40 Erie Street
Intellia Therapeutics, Inc.'s industries
research
Intellia Therapeutics, Inc.'s technology
AI Adobe Marketing Cloud Circle DNS Made Easy Drupal DynECT Google Analytics Google Tag Manager Gravity Forms Hotjar Microsoft Office 365 Mimecast Mobile Friendly Rackspace MailGun Remote Vimeo WP Engine WordPress.org
People working at Intellia Therapeutics, Inc.
MS
Ming Sun
Director Strategic Sourcing
Cambridge, Massachusetts, United States
PL
Patricia Lowden
Director, Platform Innovation Department, Protein Production & Assay Group
Cambridge, Massachusetts, United States
CD
Christian Dombrowski
Vice President - Gene Editing Platform
Cambridge, Massachusetts, United States
LP
Laura Sepp-Lorenzino, Ph.D.
Chief Scientific Officer
Cambridge, Massachusetts, United States
DK
David Karakas
Senior Director, Strategic Sourcing & Supplier Management
Cambridge, Massachusetts, United States
JG
Jia (Amanda) Guo
Principal Scientist / Ex Vivo Cell Therapy
Cambridge, Massachusetts, United States
WC
Weijun C.
Director, RNA Technologies
Cambridge, Massachusetts, United States
HK
Heather Keane
Associate Director of Strategic Sourcing and Procurement
EC
Eliana Clark
Chief Technical Officer
Cambridge, Massachusetts, United States
JE
Jackson Eby
Director, Product Technical Lead
Cambridge, Massachusetts, United States
You can find 494 people working at Intellia Therapeutics, Inc. on FinalScout. Create a free account to view details including email addresses.
Scrape emails from LinkedIn for free
20 free emails each month. No credit card required.
Regular search results
Search for leads on linkedin.com and scrape the search results
Sales Navigator search results
Search for leads in LinkedIn sales navigator and scrape the search results
Group members
Scrape members from any LinkedIn group without joining it
Event attendees
Scrape event attendees from any LinkedIn event
Directory